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Background: Tuberculosis (TB) remains a global public health problem. New cases of lung 
Tuberculosis in 2015 were 10.4 million worldwide. One of the challenging in TB control to be 
addressed is the development of Multi Drug Resistant Tuberculosis (MDR-TB). There were an 
estimated 15,380 TB cases in Indonesia by 2015 with 1,860 positive TB cases and 1,566 cases 
successfully treated. This study aimed to determine the predictor index for MDR-TB. 
Subjects and Method: This was an analytic observational study with a case-control design. The 
study was conducted at Dr. Moewardi Hospital, Surakarta, Central Java, from August to November 
2017. The study subjects were selected by fixed disease sampling including 75 MDR-TB patients 
and 75 TB patients. The dependent variable was MDR-TB. The independent variables were medical 
history, co-morbidity (Diabetes Mellitus), drug side effect, drug-taking supervisor, and regularity of 
treatment. The data were collected by questionnaire and medical record. The data were analyzed by 
a multiple logistic regression. 
Results: MDR-TB Occurrence Index increased with drug-taking supervisor (b= 2.33; 95% CI= 
3.83 to 27.91; p<0.001), drug-side effect (b = 0.73; 95%CI= 0.58 to 7.45; p=0.026),medical history 
(b= 2.35; 95%CI= 3.80 to 29.38; p<0.001). MDR-TB Occurrence Index decreased by absence of 
type 2 Diabetes Mellitus (b= -0.56; 95%CI= 0.18 to 1.78; p=0.033), regular treatment (b= -1.73; 
95%CI= 0.06 to 0.46; p<0.001). 
Conclusion: MDR-TB Occurrence Index is determined by drug-taking supervisor, drug-side 
effect, medical history, Type 2 Diabetes Mellitus, and regular treatment. 
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BACKGROUND 
Tuberculosis is still a global health pro-
blem. By 2015, there were 10.4 million new 
tuberculosis cases worldwide. Tuberculosis 
already affects 30% of the world's popu-
lation. The highest transmission is found in 
males which was about 5.9 million (59%), 
while in women, it was in the second place 
for about 3.5 million (34%), followed by 
children for about 1 million (10%) (World 
Health Organization, 2016). Every year, 
there are 1.8 deaths caused by tuberculosis, 
and transmission continues to expand in 
Asia as the world's highest infection spread. 
The Asian region contributes approxim-
mately 20% of deaths caused by tuber-
culosis, especially in developing countries 
such as India, Indonesia and China (World 
Health Organization, 2016). The high 
incidence of tuberculosis that leads to 
decreased quality of life and the impacts 
caused to death, causes tuberculosis to be a 
health problem that must be stopped, 
especially in developing countries, inclu-
ding Indonesia (Ginandjar et al., 2016). 
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Many factors that cause high inci-
dence of tuberculosis consisting of external 
factors and internal factors. External fac-
tors that influence such as distance health 
care and the environment that supports 
treatment in patients with tuberculosis. 
Internal factors may be affected by the 
treatment of the patient (Abouyannis et al., 
2014). Patient obedience in doing the 
treatment plays an important role in the 
success of tuberculosis treatment because it 
can cause resistance to tuberculosis germs 
so anti-tuberculosis drugs (OAT) can not 
prevent the spread of tuberculosis or called 
Multi Drug Resistant Tuberculosis (MDR-
TB) (Liu et al. 2015). 
Multi Drug Resistant Tuberculosis 
occurs when tuberculosis germs are resist-
ant to first-line OAT, at least two drugs are 
isoniazid and rifampicin (McClintock et al., 
2017). WHO estimates the prevalence of 
MDR-TB about 440,000 cases annually in 
the world with a mortality rate of around 
150,000. About 8.5% have been found and 
treated. In Indonesia, which is included in 
the category of High Burden Countries 
ranked 12th highest tuberculosis sufferers 
in the world, there are 8,900 cases of TB. 
2% of MDR TB cases are estimated to come 
from new TB cases and 14.7% of TB cases 
are re-treated (WHO, 2016). MDR-TB in 
Indonesia in 2015 with 15,380 cases, 1,860 
confirmed cases, and 1,566 treated 
(Infodatin, 2015).  
Indonesia is in the 9th place with the 
incidence of tuberulosis in 2015 and in 12th 
place  in 2016 (World Health Organization, 
2016). Early detection is important to 
prevent the transmission of MDR-TB 
incidence. Drug Resistant Survey (DRS) 
results indicate that in Central Java, 1.8% 
MDR-TB was found in newborn tuber-
culosis cases and 17.1% were found in TB 
cases who received treatment (DRS, 2016). 
Based on preliminary study at Moewardi 
hospital, it is known that in 2015 MDR-TB 
patients who did treatment were 1839 
visits, in 2016, there were 1.793 visits and in 
2017, there were 1.466 periods January to 
May. Resistance can occur by various 
factors, such as inadequate therapy or 
treatment (Bradley et al., 2015). 
Tuberculosis Drug Resistance (OAT) 
is strongly associated with a history of 
treatment experienced. Although in some 
cases primary resistance is found, the 
highest prevalence of MDR-TB spread still 
indicates that patients who have had 
previous treatment are at high risk of MDR-
TB. Patients with previous medical history 
had 4 times greater likelihood of resistant 
resistance and for MDR-TB 10 times 
greater than non-treated patients (Nagu et 
al., 2015). The length of TB treatment 
makes the patient saturated to run the 
treatment, then there is an important role 
of companion for the medication to monitor 
and remind the patients in the treatment. 
Resistance will be easy if the treatment is 
irregular and many treatment meetings are 
missed (Tola et al., 2016). 
The late diagnosis is suspected to be 
the causie of a wider spread of drug 
resistance strains. The wrong implemen-
tation of TB treatment can be done by the 
patient, especially in the compliance of OAT 
consumption. Termination of early treat-
ment is often encountered because the 
patient often states that they do not need to  
consume it, and the early discontinuation of 
drugs can cause resistance. One that can be 
done to detect early MDR-TB incidence is 
by making a predictor that can be used in 
looking at factors that are high risk for the 
occurrence of resistance to tuberculosis 
germs (Denkinger, Pai and Dowdy, 2014). 
Treatment of tuberculosis in Indo-
nesia is still below 85%, especially in 
central java province which has only 75% 
successful treatment of tuberculosis. One of 
Pamungkas et al./ Evaluation of Multi-Drug Resistant Tuberculosis 
e-ISSN: 2549-0273  265 
the success of tuberculosis treatment  is 
that there is no resistance in the patients. 
Therefore, the researchers are interested in 
making a predictor as a tool to prevent the 
occurrence of MDR-TB in the form of 
MDR-TB Event Index. 
 
SUBJECTS AND METHOD 
The research design used was case control. 
The target population was all tuberculosis 
and MDR-TB patients. The location of the 
research was in Dr. Moewardi hospital, 
Surakarta in August-November 2017. The 
population was MDR-TB patients who had 
been treated in Dr. Moewardi hospital. 
While the control population was tuber-
culosis patients who had been treated in Dr. 
Moewardi hospital. The inclusion criteria 
were that the patients are able to complete 
the process of taking and able to answer 
well / no psychiatric disorders. While the 
exclusion criteria were all TB patients cured 
and MDR-TB patients aged under 15 years. 
The sampling technique was simple 
random sampling with 150 samples using a 
1: 1 ratio. The number of case samples was 
75 MDR-TB patients and control samples 
were 75 tuberculosis patients.  
The independent variables were 
comorbidities (Diabetes Mellitus), drug 
side effects (ESO), drug taking supervisor, 
distance of health care, previous medical 
history, health, contact history, and charac-
teristics of study subjects (age, gender, 
education, occupation). The dependent 
variable was MDR-TB. 
MDR-TB was defined as resistant TB 
sufferers based on the results of the 
molecular rapid test examination recorded 
at Moewardi hospital. 
Drug taking supervisor was defined as 
the presence of the drug swallowing 
supervisor during treatment. Companion 
Disease (Diabetes Mellitus) was defined as 
the presence of DM disease that accom-
panies the patient during the course of 
running the TB treatment. 
Drug Side Effects (ESOs) was defined 
as the effects of tuberculosis drugs taken by 
respondents during the course of TB 
treatment. 
Distance of health services was 
defined as the time of the respondent from 
the home of the patient tothe health care 
for TB treatment. 
Previous medical history was the final 
result of treatment done by respondents 
after getting TB treatment. 
Health behavior was defined as some-
one who consumes alcohol and smokes and 
never gets BCG immunization. Contact 
history is health behavior. 
The research ethics include research 
approval, anonymity, confidentiality and 
Ethical approval. Ethical clearance in this 
study was conducted in Moewardi hospital. 
Data collection techniques used were 
medical record data and questionnaires, 
then interviews were conducted directly to 
respondents for qualitative data collection. 
The steps in performing data analysis were 
using influence analysis between inde-
pendent variable to dependent variable 
using bivariate and multivariate analysis. 
Bivariate analysis was used to determine 
the level of significance of independent and 
dependent variable influence by using Chi 
Square test. Chi square test aims to find out 
the eligible and unqualified variables to be 
continued on multivariable analysis. 
 
RESULTS 
1. Sample characteristics 
Characteristics of subjects in this study can 
be seen in table 1. 
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Table 1. The Distribution of Study Subjects 
No Characteristics 
Case Control 
N % n % 
1. Gender     
 Male 50 29.1 122 70.9 
 Female 26 19.7 106 80.3 
2. Education     
 Low 43 28.7 107 71.3 
 High 33 21.4 121 78.6 
3. Occupation     
 Not working 13 19.4 54 80.6 
 Working 63 26.6 174 73.4 
4. Marital Status     
 Single 11 21.6 40 78.4 
 Married 65 25.7 188 74.3 
5. Smoking     
 Smoking 52 36.4 91 63.6 
 Not smoking 24 14.9 137 85.1 
6. Alchohol     
 Alcohol 22 40.0 33 60.0 
 No alcohol 54 21.7 195 78.3 
7. Contact     
 Contact 18 43.9 23 56.1 
 No contact 58 22.1 205 77.9 
 
Table 1 shows that most of the 
subjects of the study were male, for about 
44 subjects or 58.7% in the case group. This 
is similar to the control group that most of 
the research subjects were male sex that is 
about 45 subjects or 60%. 
For the  education, in the case group, 
it can be interpreted that most of the 
subjects were low educated that was about 
39 subjects or equal to 52.0%. While in the 
control group, most of them awee highly 
educated which was 40 subjects or 53.3% of 
the number of research subjects. 
It can be interpreted that most of the 
research case group that is 48 subjects or 
equal (64.0%) were ≥41 years. In the 
control group, it showed that 47 subjects or 
total (62.7%) were > 41 years. 
Almost all of the research subjects in 
the case group work which was 53 subjects 
or 70.7% and most of the study subjects 
also work. While in the control group, there 
were 52 research subjects or 69.3%. 
2. Multivariate Analysis 
The result of multivariate analysis is shown 
in Figure 2. Of the 12 variables that are 
modeling candidates, there are 7 variables 
that are not included in the modeling. 
These variables do not go into modeling 
because the level of significance is more 
than 0.05 namely gender, education, 
service distance, BCG history, occupation, 
smoking, and age.  
There was a negative effect of age and 
the risk of MDR-TB occurrence (b = -0.25; 
CI95% = 0.30 to 3.01; p = 0.618). 
There was a negative relationship 
between sex and the risk of MDR-TB 
occurrence (b = -0.03; CI95% = 0.30 to 
3.01; p = 0.949). 
There was a negative relationship 
between education and the risk of MDR-TB 
occurrence (b = -0.32; CI95% = 0.28 to 
1.81; p = 0.490). 
There is a positive relationship 
between work and the risk of MDR-TB 
occurrence (b = 0.31; CI95% = 0.41 to 4.55; 
p = 0.603). 
There was a positive correlation 
between BCG history and the risk of MDR-
TB occurrence (b = 1.06; CI95% = 0.80 to 
10.44; p = 0.102). 
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There was a negative relationship 
between the distance of health care and the 
risk of MDR-TB occurrence (b = -0.52; 
CI95% = 0.23 to 1.51; p = 0.275). 
There was a positive effect of smoking 
on the risk of MDR-TB occurrence (b = 
1.18; CI95% = 1.26 to 8.44; p = 0.143). 
There was a negative association 
between Diabetes Mellitus disease and the 
risk of MDR-TB incidence was statistically 
significant (b = -0.56; CI95% = 0.18 to 1.78; 
p = 0.033). 
There was a positive effect between 
PMO on the risk of MDR-TB occurrence (b 
= 2.33; CI95% = 3.83 to 27.91; p <0.001). 
There was a positive effect between drug 
side effects and the risk of MDR-TB 
occurrence (b = 0.73; CI95% = 0.58 to 7.45; 
p = 0.026). 





95% CI  p 
Lower Limit Upper Limit 
No diabetes mellitus -0.56 0.18 1.78 0.033 
No drug taking advisor 2.33 3.83 27.91 0.000 
No side effect  -0.73 0.58 7.45 0.026 
Never forget -1.73 0.06 0.46 0.000 
Drop out 2.35 3.80 29.38 0.000 
Gender:Female -0.03 0.30 3.01 0.949 
Education≥SHS -0.32 0.28 1.81 0.490 
Services distance ≥15 Menit -0.52 0.23 1.51 0.275 
No BCG history 1.06 0.80 10.44 0.102 
Not working -0.31 0.41 4.55 0.603 
Smoking 1.18 1.26 8.44 0.143 
Age ≥45 years old -0.25 0.30 3.01 0.618 
 
There was a negative relationship 
between treatment regulation and the risk 
of MDR-TB occurrence (b = -1.73; CI95% = 
0.06 to 0.46; p <0.001). 
There was a positive relationship 
between previous treatments and the risk of 
MDR-TB occurrence (b = 2.35; CI95% = 
3.80 to 29.38; p <0.001). 
3. MDR-TB occurence Index 
Variables with significance below 0.05 
are further incorporated in the logistic 
grain model. From the analysis results, the 
index of the incidence of MDR-TB was 
found. 
Index = -3.67 + 1.73 (Treatment 
Order) + 2.33 (Drug Swallowing) + 0.73 
(Side Effects of Drug) + 0.56 (Diabetes 





There was an age influence between MDR-
TB group and non MDR-TB group. This is 
in line with a study conducted by (Lin et al., 
2016) stating that there is a relationship 
between age and MDR-TB incidence. The 
results of this study were in line with a 
theory of Soerdiawan (2015) saying that the 
most age group of MDR-TB patients is at 
the age of more than 40 years.  
Age cannot be included in MDR-TB 
incidence index because in multivariate test 
the level of significance is more than 0.005. 
Age can have an effect on MDR-TB but it is 
not significant to predict whether an elderly 
person can be at a greater risk than younger 
age for MDR-TB. This is in line with a study 
of Jia et al., (2014) stating that young or old 
age has a risk of MDR-TB because at a 
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young age TB sufferers have a productive 
age to work so often forget in taking drugs 
and finally Drop out in treatment. While in 
old age vital organs decrease in function so 
that they have the same risk. 
2. Gender 
The number of male respondents in this 
study is more than the female ones in both 
MDR-TB and non MDR-TB. The results of 
this study indicated that there was a gender 
effect between MDR-TB group and non-
MDR-TB group. The results are in line with 
(Outhred et al., 2017)’s study stating that 
most of the gender of the respondents in 
the MDR-TB group and the non-MDR-TB 
group was the male ones and Suwanpi-
molkul et al. (2017) also noted that the 
majority of MDR-TB sufferers are male. 
MDR-TB patients are dominated by 
men due to many factors, including because 
males tend to be disobedient during treat-
ment with OAT. This disobedience can lead 
to resistance to OAT (Bello, 2010). 
Although the majority of MDR-TB 
sufferers are male, it does not rule out that 
women remain at risk for TB-MDR. This 
can happen because of gender inequalities 
in which women have limited access to 
health services (World Health Organi-
zation, 2013). 
3. Education 
There was a significant relationship 
between MDR-TB and education. Another 
study done by Mediana (2002) resulting 
similar thing, which stated that educational 
level has a relationship with the incidence 
of drop out in TB patients. A high level of 
education can affect the level of TB patient 
adherence in doing anti-TB drugs (ATD) 
treatment. The higher a person's level of 
education, the higher the tendency to 
adhere to the treatment with ATD. Conver-
sely, the lower the level of knowledge, the 
lower the tendency of TB patients to 
obedient in doing a treatment with ATD. 
This was because the higher the educational 
level of TB patients, then it was assumed 
the higher the level of understanding of the 
respondents about the illness as well as the 
understanding of the instructions given by 
medical experts related to the consumption 
of ATD. 
Although the majority of MDR-TB 
sufferers have low level of education, it did 
not rule out that high education has 
sufficient knowledge of MDR-TB occur-
rence (Efsen et al., 2018). 
4. Employment 
There was a significant relationship 
between MDR-TB and employment. 
Employment would affect the TB treatment 
of TB patients due to medication adherence 
for 6 months, sometimes workers were 
busy and forget the schedule of drug 
consumption. If the patients missed the 
drug consumption schedule for one time, it 
would lead to the failure in treatment (Fox 
et al., 2017). This is in line with a study by 
Mohd, Azhar and Kamaludin, (2015), which 
stated that workers have high mobility and 
busyness, therefore, patients tend to be 
disobedient in running the treatment by 
using ATD (Yates et al., 2016).  
Although the majority of MDR-TB 
criteria were working patients, the same is 
true for non-workers of pulmonary TB 
patients who would also be busy looking for 
job or busy with their homework to support 
their living, therefore, there was no 
difference in employment status between 
non-working and working people with 
pulmonary TB (Mediana, 2002). 
5. Diabetes Mellitus Disease 
There was a relationship between MDR-TB 
and Diabetes Mellitus.  TB patients who 
have diabetes mellitus history have higher 
risk to have MDR-TB than TB patients who 
did not have diabetes mellitus history. This 
was in line with a study by Arockiaraj et al., 
(2018) which stated that the occurrence of 
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MDR-TB in patients who have TB with 
diabetes mellitus was 11.3 times greater 
than those without TB diabetes mellitus. 
The conditions of high blood glucose 
levels can affect the achievement of drugs in 
the tissues and can also interfere with the 
function of alveolar macrophage cells 
(Bashar et al., 2016). Disruption of alveolar 
macrophage cell function would decrease 
the immune system. The decrease in the 
immune system caused TB germs in the 
lungs to be resistant to the drugs. TB 
patients with diabetes mellitus were likely 
to suffer gastrointestinal damage affecting 
the absorption of ATD of rifampicin so that 
their concentration in TB patients with DM 
can not be maximized and this lead to a 
poor outcome of TB treatment and may 
cause drug resistance (Matteelli et al., 
2017). 
6. HIV/AIDS 
A study by Suchindran et al. (2009) stated 
that there was a relationship between HIV 
and MDR-TB. The relationship between 
HIV/AIDS and drug resistance cases in TB 
patients was because of the immunity 
status of TB patients that may decrease the 
effectiveness of treatment using ATD and 
therefore, it enhanced the risk of drug 
resistance (Sight 2010).  
7. Drugs Taking Supervisor 
There was a significant relationship 
between MDR-TB and drug taking super-
visor. This study was in line with a study by 
Soebarko (2017) which stated that drug 
taking supervisor affected the incident of 
MDR-TB. TB patients without drug taking 
supervisor have 19 times higher risk than 
TB patients who have drug taking super-
visor. TB treatment took a long time and 
should be done every day. In addition, TB 
treatment would also cause side effects for 
those who consume it and would cause a 
sense of boredom and saturation. It was the 
boredom and saturation that would cause 
TB sufferers to stop their treatment which 
would give them a greater chance of 
becoming MDR-TB. 
Drug taking supervisor was one of the 
successful factors of DOTS program and the 
successful of therapy because it would 
affect the adherence of TB patients in 
taking ATD so that the patients were 
motivated to take medicine regularly. Drug 
taking supervisor was needed to ascertain 
whether the drug was actually taken or not 
(Burner, 2017). 
8. Health Services Distance 
There was a significant relationship 
between MDR-TB and the distance of 
health services. Although statistically the 
travel time did not affect the occurrence of 
MDR-TB, but the location of the TB 
patient's residence to the health service 
would affect the TB patients' regularity in 
the treatment process. TB patients who live 
far away from the service center would find 
the difficulty in taking the medication every 
month. The long travel time of respondents 
indicated that the access to health services 
was also far and took longer time. The 
result of this study was in line with a study 
by Sondakh (2014), which stated that there 
was a relationship between the distance to 
health services with the occurence of MDR-
TB. Prolonged travel time may be consi-
dered as one of the causes of tuberculosis 
sufferers to not perform routine treatment 
at the nearest health service center  
(Pedriacan, 2017). 
9. Alcohol Consumption 
Health behavior of alcohol consumption did 
not affect the occurrence of MDR-TB, 
because there was no difference between 
health behavior of alcohol consumption on 
MDR-TB groups and non MDR-TB. This 
was because Indonesian people, especially 
in Surakarta considered drinking alcohol as 
a thing that is prohibited by religion. 
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The result of this study was in line 
with Fauziah (2003), who stated that there 
was no relationship between alcohol 
consumption and the occurrence of MDR-
TB. In contrast to the results of a study 
conducted by Trinnawoottipong (2012) in 
Thailand, which stated that TB patients 
who drink alcohol as their habit have 5.1 
times higher risk to become MDR-TB.  
10. Smoking  
There was a significant relationship 
between MDR-TB and smoking. According 
to the research by Barroso et al. (2003), 
there was an effect between smoking beha-
vior and the occurrence of MDR-TB and 
smoking was one of the risk factors of 
MDR-TB. Continuous smoking behavior 
would result in disruption of the lung 
defense system that affected the destruction 
of alveolar macrophages so that it decrea-
sed the immune system. The decrease of 
the immune system caused TB germs in the 
lungs to be resistant to the drugs. 
Acquired drug resistency lead to the 
organ damage which was not caused by 
smoking. To ensure that smoking was a risk 
factor for MDR-TB in TB patients, data on 
the age at first time smoking and the 
duration of smoking history were required 
(the number of cigarette per day, the con-
tent of cigarettes and the type of cigarette) 
(Riza, 2015). 
11. BCG History 
There was a significant relationship 
between MDR-TB and BCG history. This 
was in contrast with a study done by  
Sondakh (2014), which stated that there 
was no effect of BCG immunization status 
marked by a scar on the occurrence of 
MDR-TB. BCG immunization was effective 
to prevent miliary TB, TB meningitis and 
TB spondylitis in children. BCG immu-
nization was given to provide the protection 
against tuberculosis. BCG immunization 
caused active immunity to prevent the 
development of TB germs in the occurrence 
of infection (Basic Health Research, 2010). 
BCG immunization only provide pro-
tection against tuberculosis bacterial infec-
tion, it was not for drug-resistant tuber-
culosis germs due to errors in the treat-
ment. Some of the causes of MDR-TB were 
due to inadequate drug use and irregular 
treatment (Hermina, 2013). 
12. Medical History of Regular 
Treatment 
There was a relationship between MDR-TB 
and the regular treatment. In an interview 
conducted to MDR-TB patients in this 
study, the irregularity or non-compliance of 
respondents in drinking ATD was because 
the respondents often forget to drink ATD. 
In addition, some respondents complained 
about TB services in poor health services. 
The irregularity of TB patients in previous 
treatment periods would result in genetic 
mutations of M tuberculosis so that anti-TB 
drugs were not effective against TB germs. 
When anti-TB drugs were no longer 
effective against TB germs, the chances of 
becoming an MDR-TB would be greater 
(Sarwani, 2012). 
13. Previous Treatment 
There was a relationship between MDR-TB 
and the previous treatment. This was in line 
with Mulisa (2015), who stated that there 
was an effect of failure or drop out previous 
TB treatment outcomes with the occurrence 
of MDR-TB. TB patients with a failed or 
dropped out history of TB treatment had a 
3.5 times higher risk than those with TB 
who had recovery history of treatment out-
come. Drop out or failure of TB treatment 
was one of the causes of drug resistance. TB 
treatment performed for more than two 
months can lead to the drop out for  the 
patient because after intensive treatment, 
patients usually feel healed and they would 
stop the treatment. 
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Previous therapy outcomes such as 
drop-outs can show the non-adherence of 
TB patients in implementing TB treatment, 
and it would increase the risk of MDR-TB, 
whereas previous TB treatment outcomes 
such as cured and complete treatment can 
show TB patients' adherence to treatment 
so that the risk of MDR-TB was smaller 
(Pinto and Carvalho, 2017). 
14. Drug-Side Effect  
There was a significant relationship 
between MDR-TB and drug-side effect. The 
result of this study was in line with a study 
by Lee et al., (2014), which stated that the 
side effect of ATD was the risk factor of 
MDR-TB. Factors relating to adherence 
treatment of pulmonary tuberculosis pati-
ents with control case design showed a 
significant relationship between drug side 
effects with adherence of pulmonary tuber-
culosis patients to regular treatment. 
Pulmonary TB sufferers who feel the side 
effects of drugs have the opportunity to 
stop the treatment. 
Pulmonary TB sufferers who feel the 
side effects of ATD tend to stop the treat-
ment (McBryde et al., 2017), this condition 
lead the TB sufferers into drop out. When 
TB patients do not perform the treatment 
completely, it would occur genetic mutation 
of M. tuberculosis bacteria which was 
resistant to ATD (Kigozi et al., 2017). 
15. Contact History 
Based on the interview results to the 
respondents, most of them admitted that 
they have no contact to TB sufferers and did 
not know whether the people around them 
have MDR-TB or not. This study was in line 
with a study by Fox et al., (2017), which 
stated that there was no relation between 
contact history and the occurrence of MDR-
TB. Contact history had no effect in this 
study because all respondents in the MDR-
TB group had a previous history of TB 
disease, where the outcome of previous TB 
treatment was a failure or drop out. 
16. Model of MDR-TB Index 
Based on multivariate analysis result using 
multiple logistic regression, the most influ-
encing factor on MDR-TB occurrence in 
Surakarta was the availability factor of DSC, 
the regularity of ATD consumption, adverse 
side effects of ATD, previous TB treatment 
outcomes and comorbidities of diabetes 
mellitus. These five factors were the indi-
cators in the preparation of MDR-TB occur-
rence index. Formula of MDR-TB occur-
rence index in Surakarta. 
This prediction index can predict the 
risk of MDR-TB occurrence in Surakarta 
with 93.4%  sensitivity and 80.3% speci-
ficity with measurement accuracy by 89.3%. 
This prediction index can be used to predict 
the occurrence of MDR-TB in people with 
TB. Based on this, the MDR-TB risk 
management that can be implement was to 
identify the most risky variables to TB 
patients. The findings in this study can be 
implemented to the MDR-TB disease pre-
vention program by intervening in the 
socialization of the most influencing factors 
on the occurrence of MDR-TB. The imple-
mentation of MDR-TB occurrence index in 
Surakarta can be used by the officers both 
at health service level and health 
department by using MDR-TB occurrence 
index algorithm. 
17. Evaluation of MDR-TB Occur-
rence Index 
This study evaluated the steps in the cycle, 
which consist of reviewing the findings, 
developing the research results, conducting 
field trials, and revising the results obtained 
(Mohd et al., 2015).  
The assessment of MDR-TB occur-
rence index  
The result of this study was the MDR-TB 
occurrence index that can be predicted 
whether it has high or low risk to become 
Journal of Epidemiology and Public Health (2018), 3(2): 263-276 
https://doi.org/10.26911/jepublichealth.2018.03.02.06 
272   e-ISSN: 2549-0273 
MDR-TB. It was expected that this index 
can be used to be screening tools in  
determining high-risk populations of MDR-
TB.  
In the results of quantitative data 
collection, five variables were found to be 
candidates in the MDR-TB occurrence 
index, then the index was applied to 3 
people with MDR-TB by interviewing 
retrospective MDR-TB sufferers. 
The results of interview from Mr. H 
(respondent) showed that he did not have 
DSC, doing irregular treatment and never 
drop out. The assessment of MDR-TB 
occurrence index was shown in Table 3.
Table 3. The Assessment of MDR-TB Occurrence Index of Mr. H  
No Measurement results Score Weight Weight x Score 
1 Drug taking advisor    
 a. Yes                            
1 2.33 2.33 
 b. No  
2 Regular Treatment    
 a. Never Forget 
1 1.73 1.73 
 b. Ever Forget 
3 Drug-Side Effect    
 a. No Drug-Side Effect 
0 0.73 0 
 b. With Drug-Side Effect 
4 Previous Treatment History    
 a. Recover or Complete Treatment 
1 2.35 2.35 
 b. Failure / Drop Out 
5 The Comordibities of DM    
 a. DM 
0 0.56 0 
 b. No DM 
 TOTAL   6.41 
 Index Score -3.67 + 6.41 2.74 
 
It can be concluded in the case of Mr. 
H, that he has a high risk for the occurrence 
of MDR-TB. This can be seen from the 
scores of high occurrence of MDR-TB index 
that is 2.74 which was higher than Cut off 
Index score by -0.296. The case in Mr. H 
was only as an evaluation to the accuracy 
test of the Index so that the Index can be 
applied to TB patients to prevent or reduce 
the risk of MDR-TB. 
In Respondent 2, who was Mrs. I, the 
results of the interview showed that there 
were 4 variables related to candidate index 
of MDR-TB occurrence in Mrs. I's MDR 
history, which were DSC, treatment 
irregularities and side effects of treatment 
and the comorbidities. The results of the 
data were included in the assessment form 
of MDR-TB occurrence index according to 
the scores obtained, as in the following 
Table 4. 
It can be concluded in Mrs. I's case 
that she has a high risk for the occurrence 
of MDR-TB. This can be seen from the 
score value of high occurrence index of 
MDR-TB that is 1.68, which is higher than 
Cut off Index score -0.30. 
It can be concluded in Mrs. I's case 
that she has a high risk for MDR-TB. This 
can be seen from the score value of high 
occurrence index of MDR-TB that is 2.74, 
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Table 4. The Assessment of MDR-TB Occurrence Index of Mrs. I  
No Measurement results Score Weight Weight x Score 
1 Drug taking advisor    
 a. Yes                             
1 2.33 2.33 
 b. No  
2 Regular Treatment    
 a. Never Forget 
1 1.73 1.73 
 b. Ever Forget 
3 Drug-Side Effect    
 a. No Drug-Side Effect 
1 0.73 0.73 
 b. With Drug-Side Effect 
4 Previous Treatment History    
 a. Recover or Complete Treatment 
0 2.35 0 
 b. Failure / Drop Out 
5 The Comordibities of Diabetes millitus    
 a. DM 
1 0.56 0.56 
 b. No DM 
 TOTAL   5.35 
 Index Score -3.67 + 5.35 1.68 
 
Table 4. The Assessment of MDR-TB Occurrence Index of Mrs. S 
No Measurement results Score Weight Weight x Score 
1 Drug taking advisor    
 a. Yes                            
1 2.33 2.33 
 b. No  
2 Regular Treatment    
 a. Never Forget 
1 1.73 1.73 
 b. Ever Forget 
3 Drug-Side Effect    
 a. No Drug-Side Effect 
0 0.73 0 
 b. With Drug-Side Effect 
4 Previous Treatment History    
 a. Recover or Complete Treatment 
1 2.35 2.35 
 b. Failure / Drop Out 
5 The Comordibities of Diabetes millitus    
 a. DM 
0 0.56 0 
 b. No DM 
 TOTAL   6.41 
 Index Score -3.67 + 6.41 2.74 
 
The Implementation of MDR-TB 
Index 
The implementation of the research results 
was using algorithm of MDR-TB occurrence 
index that can be used by all circles, both 
community and health workers. The use of 
this MDR-TB occurrence index algorithm 
can predict the occurrence of MDR-TB in 
people with TB, the users no longer need to 
calculate the MDR-TB index score of TB 
sufferers. To predict whether a person with 
TB has a high or low risk of becoming an 
MDR-TB, the user of this algorithm was 
required to follow the plot of the scheme, 
starting from the aspect of DSC availability, 
regularity in ATD, side effects of ATD, 
previous result of TB treatment, and the 
last one was diabetes mellitus disease. 
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